Used in clinical and research laboratories to measure glycated serum protein levels in human blood samples, this ELISA kit helps assess short- to medium-term blood glucose control, typically reflecting average glucose levels over the past 2 to 3 weeks. It is particularly useful in monitoring diabetic patients where HbA1c measurements may be unreliable, such as in cases of hemoglobinopathies, anemia, or during pregnancy. The kit supports studies on glycemic variability, insulin resistance, and the effectiveness of antidiabetic therapies. Due to its ability to capture recent changes in glucose levels, it is also employed in evaluating dietary interventions and treatment adjustments in diabetes management research.